AVITA MEDICAL CDI 5:1 (AVH) News
Latest articles and price-sensitive announcements with AI sentiment classification.
ASXAVITA Highlights first UK Clinical Experience with RECELL GO
other announcement
Change of Director's Interest Notice -SC JCC RM JSR MT CV JW
director_dealing announcement
Notification regarding unquoted securities - AVH
other announcement
Change of Director's Interest Notice - JW
director_dealing announcement
Notification regarding unquoted securities - AVH
other announcement
Financial Results for Quarter Ending 31 March 2026
other announcement
AVITA Medical Reports First Quarter 2026 Financial Results
other announcement
AVITA Medical Names Cary Vance as Chief Executive Officer
other announcement
AVITA Secures Australia & NZ Clearance for RECELL GO
other announcement
AVITA to Announce First Quarter 2026 Financial Results
other announcement
AVITA KOL Investor Webinar Presentation on Cohealyx
other announcement
AVITA Announces Positive Interim Results from Cohealyx study
other announcement
AVITA Shelf Registration Statement Filed with the SEC
other announcement
Update - Notification regarding unquoted securities - AVH
other announcement
Notification regarding unquoted securities - AVH
other announcement
AVITA to participate at TD Cowen Annual Health Conference
other announcement
AVITA Investor Briefing Presentation February 2026
other announcement
AVITA Reports Q4 and Full Year 2025 Financial Results
other announcement
Notice under section 708A(5)(e) of the Corporations Act
other announcement
Notification regarding unquoted securities - AVH
other announcement